The popular heartburn/antacid drug Zantac (ranitidine) was officially recalled by the US Food and Drug Administration (FDA) on April 1, after investigations found that it contains unsafe levels of the carcinogen N-nitrosodimethylamine (NDMA). There have been a number of lawsuits filed against Zantac’s manufacturers by consumers diagnosed with cancer.
The petition for this recall was submitted by Valisure, the drug testing company which conducts routine reviews of Zantac and other drugs. After the petition in September 2019, further testing showed that NDMA levels can increase with higher temperatures, including during storage and when being processed by the body.
How Does Zantac Cause Breast Cancer?
A 2008 study at the Fred Hutchinson Cancer Research Center presented a direct link between Zantac and breast cancer. The results of this study showed that patients who took the drug regularly had an increased risk of developing breast cancer by 240% in contrast to those who did not consume ranitidine.
The NDMA found in Zantac samples has been known as a cancer risk for decades. The chemical can be produced both naturally and artificially, and was previously used in the production of rocket fuel and plastics. It is not produced or commercially used in the US, except for in laboratory research where it is primarily used to induce tumor growth in animal testing.
There are a number of ways you can be exposed to NDMA, including ingesting foods with high levels of nitrosamines such as cured meats and cheese, ingesting foods treated with alkylamine pesticides, and smoking cigarettes. As a reference, the FDA set a “permissible daily intake limit of 96 nanograms (ng) of NDMA. While items such as a hot dog, that can contain 30-120 ng, and a single filtered cigarette which has between 5-43 ng, testing found samples of Zantac with NDMA levels over 3 million ng.
Breast Cancer Lawsuits Against Zantac Manufacturers
A Florida woman filed a lawsuit in December of 2019 to seek compensation for her breast cancer diagnosis in August of that year. She had been taking Zantac to treat her chronic heartburn for nearly two decades when she received her diagnosis. In another Florida case, a man was taking Zantac to calm his acid reflux and heartburn for nine years starting in 2009 and was diagnosed with breast cancer in 2013.
Both of these suits assert that Zantac producers had the responsibility to know about its carcinogenic effects and release this information to the public and medical community, but did no such thing. In fact, despite knowledge of NDMA’s harmful properties since the 1970s, Zantac has been marketed as safe since it was introduced to the market in 1983. Millions of Americans have been treating their indigestion, heartburn, and acid reflux with ranitidine for years or possibly even decades.
Breast cancer patients who were diagnosed caused by regular Zantac use deserve compensation. Our experienced team of lawyers at Kwartler Manus, LLC can assist you in collecting the restitution you are entitled to and does not rest until justice is served.
What Other Cancers Does Zantac Possibly Cause?
In addition to breast cancer, people who have developed any of the following cancers caused by consistent and prolonged use of ranitidine drugs may be eligible for compensation:
Small intestine cancer
How Can We Help You?
If you or someone you love has been diagnosed with breast cancer or cancer in the above list after ingesting Zantac (ranitidine) on a regular basis, contact us at the law firm of Kwartler Manus, LCC. Our Zantac attorneys can help you navigate the complex litigation process and receive the compensation that you deserve. Filing a mass tort claim against Zantac manufacturers can also help save others from future pain and suffering. Contact us today online or by phone at (267) 214-8608.